Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2024

08-08-2023 | Addiction | Original Research

Hospital Addiction Medicine Consultation Service Orders and Outcomes by Patient Race and Ethnicity in an Urban, Safety-Net Hospital

Authors: Amber R. Lindsay, MD, MPH, Tyler N. A. Winkelman, MD, MSc, Gavin Bart, MD, PhD, Michael T. Rhodes, MD, Riley D. Shearer, MSc

Published in: Journal of General Internal Medicine | Issue 2/2024

Login to get access

Abstract

Background

Hospital admissions involving substance use disorders are increasing and represent an opportunity to engage patients in substance use treatment. Addiction medicine consultation services improve access to medications for opioid use disorder (MOUD) and patient outcomes. However, as hospitals continue to adopt addiction medicine consultation services it is important to identify where disparities may emerge in the process of care.

Objective

To describe addiction medicine consultation service use by race and ethnicity as well as substance to identify opportunities to reduce substance use treatment disparities.

Design

Retrospective cohort study using 2016–2021 Electronic Health Record data from a large Midwest safety-net hospital.

Participants

Hospitalized adults aged 18 or older, with one or more substance use disorders.

Main Measures

Consultation orders placed, patient seen by consult provider, and receipt of MOUD by self-reported race.

Key Results

Between 2016 and 2021, we identified 16,895 hospitalized patients with a substance use disorder. Consultation orders were placed for 6344 patients and 2789 were seen by the consult provider. Black patients were less likely (aOR = 0.58; 95% CI: 0.53–0.63) to have an addiction medicine consultation order placed and, among patients with a consultation order, were less likely (aOR = 0.74; 95% CI: 0.65–0.85) to be seen by the consult provider than White patients. Overall, Black patients with OUD were also less likely to receive MOUD in the hospital (aOR = 0.63; 95% CI: 0.50–0.79) compared to White patients. However, there were no differences in MOUD receipt among Black and White patients seen by the consult provider.

Conclusions

Using Electronic Health Record data, we identified racial and ethnic disparities at multiple points in the inpatient addiction medicine consultation process. Addressing these disparities may support more equitable access to MOUD and other substance use treatment in the hospital setting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lindsay AR, Shearer RD, Bart G, Winkelman TNA. Trends in substance use disorder-related admissions at a safety-net hospital, 2008-2020. Journal of Addiction Medicine. Published online Under Review 2021. Lindsay AR, Shearer RD, Bart G, Winkelman TNA. Trends in substance use disorder-related admissions at a safety-net hospital, 2008-2020. Journal of Addiction Medicine. Published online Under Review 2021.
3.
go back to reference Fingar KR, Owens PL. Opioid-Related and Stimulant-Related Adult Inpatient Stays, 2012–2018: Statistical Brief #271. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Healthcare Research and Quality (US); 2021. Accessed June 14, 2021. http://www.ncbi.nlm.nih.gov/books/NBK568393/ Fingar KR, Owens PL. Opioid-Related and Stimulant-Related Adult Inpatient Stays, 2012–2018: Statistical Brief #271. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Healthcare Research and Quality (US); 2021. Accessed June 14, 2021. http://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK568393/​
10.
11.
go back to reference Ober AJ, Murray-Krezan C, Page K, et al. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder. Addiction Science & Clinical Practice. 2022;17(1):39. https://doi.org/10.1186/s13722-022-00320-7CrossRef Ober AJ, Murray-Krezan C, Page K, et al. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder. Addiction Science & Clinical Practice. 2022;17(1):39. https://​doi.​org/​10.​1186/​s13722-022-00320-7CrossRef
21.
go back to reference Andraka-Christou B. Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder. Health Affairs. 2021;40(6):920-927.CrossRefPubMed Andraka-Christou B. Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder. Health Affairs. 2021;40(6):920-927.CrossRefPubMed
26.
go back to reference DeLaquil M. Differences in Rates of Drug Overdose Deaths by Race. Minnesota Department of Health; 2020:17. DeLaquil M. Differences in Rates of Drug Overdose Deaths by Race. Minnesota Department of Health; 2020:17.
Metadata
Title
Hospital Addiction Medicine Consultation Service Orders and Outcomes by Patient Race and Ethnicity in an Urban, Safety-Net Hospital
Authors
Amber R. Lindsay, MD, MPH
Tyler N. A. Winkelman, MD, MSc
Gavin Bart, MD, PhD
Michael T. Rhodes, MD
Riley D. Shearer, MSc
Publication date
08-08-2023
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 2/2024
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-023-08356-4

Other articles of this Issue 2/2024

Journal of General Internal Medicine 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine